Virtual Medicinal Product (VMP) - Triptorelin acetate 3mg powder and solvent for prolonged-release suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Triptorelin acetate 3mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-01-2025 End Date
Previous Name Previous Name Triptorelin acetate 3mg powder and solvent for suspension for injection vials Start Date 15-11-2012 End Date 31-12-2024
Abbreviated Name Abbreviated Name Triptorelin acetate 3mg inj vials Start Date 15-11-2012
Previous Abbreviated Name Triptorelin acetate 4.2mg inj vials Previous Start Date 14-01-2011 Previous End Date 14-11-2012

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for prolonged-release suspension for inj
Ontology Form/Route
suspensioninjectionprolonged-release.intramuscular
Name Basis
INNM - International Non-proprietary Name (Modified)

Codes

ATC Code
L02AE04
BNF Start Date End Date
Current BNF 08030402 Start Date 04-04-2022 End Date
Previous BNF 08030402 Start Date 14-02-2005 End Date 03-04-2022
Previous BNF 06070200 Start Date 14-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36145411000001101 05-11-2018
327371000 26-03-2003 04-11-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Triptorelin acetate Based on Base Substance Triptorelin 3 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 6900 Part VIIIA Category C